Introduction: Who Should Seek Diagnostic Testing

If you notice a painful skin wound that appears suddenly and grows quickly, it’s important to see a healthcare professional without delay. Pyoderma gangrenosum often starts as a small bump, spot, or blister that may look harmless at first, similar to an insect bite. However, within days, this can break down and turn into a large, open sore with a purple or blue edge.^[1]

You should seek diagnostic evaluation if you develop a skin ulcer that isn’t healing, especially if it seems to be expanding rapidly. This is particularly important if you already have certain medical conditions. People with inflammatory bowel disease (such as ulcerative colitis or Crohn’s disease), rheumatoid arthritis, or blood disorders are at higher risk of developing pyoderma gangrenosum.^[2] If you notice a painful wound developing near a surgical site, around a stoma, or after any skin injury, this also warrants immediate medical attention, as the condition can be triggered by trauma to the skin.^[1]

Anyone experiencing severe pain from a skin wound that seems out of proportion to its size should not wait to get help. The pain from pyoderma gangrenosum can be intense and disabling, often interfering with sleep and daily activities. Early diagnosis makes treatment more effective and can prevent the ulcer from becoming larger and more difficult to manage.^[17]

Classic Diagnostic Methods

Diagnosing pyoderma gangrenosum can be challenging because there is no single test that can confirm the condition with certainty. Instead, doctors rely on a combination of careful examination, medical history, and tests to rule out other conditions that might cause similar symptoms. This process is known as diagnosis of exclusion, meaning other possible causes must be eliminated before confirming pyoderma gangrenosum.^[3]

Clinical Assessment and Physical Examination

The first step in diagnosis involves a thorough discussion between you and your healthcare provider about your symptoms and medical history. Your doctor will want to know when the wound first appeared, how quickly it has grown, and whether you have any underlying health conditions. They will also ask about any recent injuries or surgeries to the affected area.^[10]

During the physical examination, your doctor will carefully inspect the ulcer. Pyoderma gangrenosum has some characteristic features that help with identification. The edge of the ulcer typically appears purple or violet and may be undermined, which means the skin at the border hangs over the wound base, as if the tissue underneath has been eaten away. The ulcer itself is usually very painful and may ooze fluid. On white skin, the borders often look blue or purple; on brown or black skin, the area around the ulcer may appear darker than the surrounding skin.^[2]

The location of the ulcer also provides clues. Pyoderma gangrenosum most commonly affects the legs, but it can appear anywhere on the body, including the arms, trunk, around surgical openings (stomas), or near surgical wounds.^[5]

Skin Biopsy

A skin biopsy is often performed as part of the diagnostic process. This involves removing a small sample of tissue from the edge of the ulcer and examining it under a microscope in a laboratory. While pyoderma gangrenosum doesn’t have a specific appearance that confirms the diagnosis, the biopsy is very helpful in ruling out other conditions, such as skin cancer, infections, or inflammation of blood vessels.^[7]

Under the microscope, tissue from pyoderma gangrenosum typically shows a large number of white blood cells called neutrophils. These are cells that normally fight infections, but in pyoderma gangrenosum they accumulate in the skin even though there’s no infection present. This finding supports the diagnosis but is not specific enough on its own to confirm it.^[9]

Tests to Rule Out Other Conditions

Because pyoderma gangrenosum can look like many other conditions, your doctor will need to exclude these possibilities. A wound swab may be taken to test for bacterial, fungal, or other infections. Even though pyoderma gangrenosum is not caused by infection, the ulcer can become secondarily infected, which needs to be identified and treated.^[7]

Blood tests may be ordered to check for signs of inflammation or underlying conditions associated with pyoderma gangrenosum. These might include tests for inflammatory bowel disease, rheumatoid arthritis, or blood disorders. Your doctor may also request urine and stool tests to help identify related health problems.^[7]

In some cases, imaging tests such as X-rays or ultrasound may be performed to rule out problems with blood vessels, particularly if there’s concern about poor circulation causing the wound. However, these tests are only done when the clinical picture suggests they might be helpful.^[23]

Observing the Response to Injury (Pathergy)

One distinctive feature of pyoderma gangrenosum is something called pathergy. This means that new ulcers can develop after even minor skin injuries, such as cuts, scratches, or surgical procedures. In fact, about 30% of patients with pyoderma gangrenosum experience this phenomenon.^[6] If a wound worsens dramatically after surgical cleaning (debridement) or if new ulcers appear at sites of minor trauma, this strongly suggests pyoderma gangrenosum.^[6]

Because of pathergy, surgery is generally avoided in people with suspected or confirmed pyoderma gangrenosum, as cutting into the skin can trigger new wounds or make existing ones worse.^[7]

Diagnostic Criteria

To help doctors make an accurate diagnosis, some medical experts have developed diagnostic criteria based on combinations of clinical features and test results. One widely recognized approach requires meeting one major criterion (such as characteristic appearance on tissue biopsy showing neutrophil infiltration) along with four out of eight minor criteria. These minor criteria include things like excluding infection, having a history of inflammatory bowel disease or arthritis, observing pathergy, and noting the typical appearance of the wound edge.^[15]

The diagnosis process can take time and may require multiple visits or consultations with specialists, particularly dermatologists who have experience with rare inflammatory skin conditions.^[17]

Diagnostics for Clinical Trial Qualification

When patients with pyoderma gangrenosum are being considered for enrollment in clinical trials, additional diagnostic procedures and criteria are often applied. Clinical trials test new treatments or approaches to managing the condition, and they need to ensure that participants truly have pyoderma gangrenosum and meet specific standards.

Standardized Diagnostic Criteria

Clinical trials typically use validated diagnostic criteria to confirm that potential participants have pyoderma gangrenosum. One example is a scoring system that requires meeting one major criterion and four of eight minor criteria, which has been shown to have high sensitivity and specificity for diagnosing the condition.^[15] This standardization ensures that all trial participants have a comparable condition, which makes the study results more reliable.

Baseline Disease Assessment

Before enrolling in a clinical trial, patients undergo a comprehensive baseline assessment to document the extent and severity of their pyoderma gangrenosum. This includes careful measurement of ulcer size, documentation of the number of ulcers, assessment of pain levels, and evaluation of how the condition affects daily functioning. Photographs may be taken to provide a visual record of the wounds at the start of the trial.^[11]

These baseline measurements are crucial because they allow researchers to track whether the treatment being studied actually helps. By comparing the wound at the beginning and end of the trial, doctors can see if it has healed, shrunk, or remained the same.

Laboratory Tests and Screening

Clinical trials often require specific blood tests to assess overall health and to check for underlying conditions that might affect treatment. Blood work may include tests for inflammatory markers (such as C-reactive protein or CRP), complete blood counts, liver and kidney function tests, and screening for infections that could interfere with the trial treatment.^[15]

If the trial involves testing a medication that suppresses the immune system or targets specific inflammatory pathways, additional specialized tests may be needed to ensure the patient can safely receive that treatment. For example, tests might check immune cell counts or levels of specific proteins involved in inflammation.

Confirmation of Associated Conditions

Since about half of people with pyoderma gangrenosum have an underlying condition such as inflammatory bowel disease, rheumatoid arthritis, or a blood disorder, clinical trials may require documentation of these associated diseases.^[4] This might involve reviewing medical records, performing colonoscopy for suspected bowel disease, or conducting specialized blood tests for arthritis or blood disorders. Some trials specifically recruit patients who have both pyoderma gangrenosum and another condition, particularly if the treatment being studied is expected to help both problems.^[15]

Tissue Biopsy Confirmation

Most clinical trials require that participants have had a tissue biopsy to help confirm the diagnosis and rule out other conditions. The biopsy results are reviewed to ensure they show the typical neutrophilic infiltration seen in pyoderma gangrenosum and to exclude cancer, infection, or other inflammatory diseases.^[15]

Exclusion of Infection

Because infections can complicate pyoderma gangrenosum and affect how well treatments work, clinical trials typically require that active infections be identified and treated before a patient can enroll. Wound cultures may be taken, and if infection is found, patients must complete antibiotic treatment before joining the study.^[15]

Assessment of Previous Treatments

Researchers need to know what treatments patients have already tried and how well they worked. This information helps determine whether a patient is eligible for a particular trial. Some studies specifically look for patients who haven’t responded to standard treatments, while others may require that patients haven’t received certain medications for a specified period before enrollment.^[11]

Documentation of current medications is also important, as some drugs might interact with the trial treatment or affect the study results. Patients may need to stop or adjust certain medications before or during the trial.

Ongoing Monitoring During Trials

Once enrolled, trial participants undergo regular assessments to monitor their progress and watch for any side effects from the treatment being studied. This includes repeated measurements of wound size, pain assessments, quality of life questionnaires, blood tests to monitor drug levels or side effects, and physical examinations. This careful monitoring helps researchers understand whether the treatment is working and whether it’s safe.^[11]